Table 4 Unadjusted mean PSQI_PW scores pre and post treatment – stratified by primary diagnosis for hospitalization and sedative-hypnotic drug type
Mean Pre-Score (SD) | Mean Post-Score (SD) | Pre-Post change (%) | Mean difference (95% CI) | p-value (Bonferroni-adjusted) | |
|---|---|---|---|---|---|
4(a). Primary diagnosis | |||||
Cardiovascular diseases | 11.01 (3.27) | 5.25 (2.11) | −5.76 (52.3%) | 5.6 (4.4,6.7) | < 0.001 |
Respiratory diseases | 13.83 (3.86) | 7.46 (3.01) | −6.37 (46.1%) | 6.7 (5.3,8.1) | < 0.001 |
Infectious diseases | 13.28 (3.27) | 4.96 (2.81) | −8.32 (62.7%) | 8.3 (6.6,10.1) | < 0.001 |
Psychiatric disorders | 13.75 (3.01) | 7.25 (2.85) | −6.50 (47.3%) | 6.5 (5.1,7.9) | < 0.001 |
Fractures | 15.71 (3.05) | 5.79 (2.55) | −9.93 (63.2%) | 9.9 (7.8,12.0) | < 0.001 |
Urologic diseases | 11.31 (2.41) | 5.38 (2.68) | −5.92 (52.3%) | 5.9 (4.6,7.3) | < 0.001 |
Other diseases | 11.21 (3.81) | 3.93 (2.13) | −7.29 (65.0%) | 7.3 (4.8,9.7) | < 0.001 |
4(b). Sedative-hypnotics | |||||
Alprazolam | 11.76 (3.51) | 5.31 (2.70) | −6.45 (54.8%) | 6.5(5.6,7.3) | < 0.001 |
Clonazepam | 12.00 (3.82) | 5.83 (2.68) | −6.17 (51.4%) | 6.2 (5.0,7.3) | < 0.001 |
Zolpidem | 14.32 (3.02) | 6.41 (2.87) | −7.91 (55.2%) | 7.9 (6.7,9.1) | < 0.001 |
Lorazepam | 13.32 (3.24) | 6.73 (2.99) | −6.59 (49.5%) | 6.6 (4.8,8.4) | < 0.001 |
Nitrazepam | 13.25 (1.26) | 7.00 (2.94) | −6.25 (47.2%) | 6.3 (2.0,10.5) | 0.0894 |